Prague Registry of Electric Cardioversion

NCT ID: NCT04919902

Last Updated: 2021-06-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-01

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This single-center observational registry follows contemporary efficacy and short-term complications of elective electric cardioversion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation Atrial Flutter Atrial Arrhythmia Atrial Tachycardia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Electric cardioversion

Patients who underwent elective cardioversion for atrial arrhythmia

Electric cardioversion

Intervention Type PROCEDURE

Electric cardioversion in short sedation according to established clinical practice and indications

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electric cardioversion

Electric cardioversion in short sedation according to established clinical practice and indications

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Consecutive out-patients undergoing electric cardioversion for atrial fibrillation, atrial tachycardia, or typical atrial flutter

Exclusion Criteria

* Unstable patients with acute conditions requiring unplanned hospitalization
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institute for Clinical and Experimental Medicine

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marek Sramko

Head of the Department of Acute Cardiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute for Clinical and Experimental Medicine (IKEM)

Prague, , Czechia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marek Sramko, MD, PhD

Role: primary

+420731682681

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EKV2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Differentiate AVNRT from Orthodromic AVRT
NCT06671145 NOT_YET_RECRUITING NA